Page 569 - Multidisipliner Covid 19
P. 569

COVID-19 Pandemisi ve Kalp-Damar Sistemi


                   KAYNAKLAR


                   1.  World Health Organization. Director-General's remarks at the media
                       briefing on 2019-nCoV on 11 February 2020. https://www.who.int/
                       dg/speeches/detail/who-director-general-s-remarks-at-the-media-
                       briefing-on-2019-ncov-on-11-february-2020 (Accessed on February
                       12, 2020).
                   2.  Centers for Disease Control and Prevention. 2019 Novel coronavirus,
                       Wuhan, China. Information for Healthcare Professionals.https://www.
                       cdc.gov/coronavirus/2019-nCoV/hcp/index.html (Accessed on
                       February 14, 2020).
                   3.  World Health Organization. Novel Coronavirus (2019-nCoV) technical
                       guidance. https://www.who.int/emergencies/diseases/novel-coro-
                       navirus-2019/technical-guidance (Accessed on February 14, 2020).
                   4.  WHO Director-General's opening remarks at the media briefing on
                       COVID-19 - 24 February 2020 https://www.who.int/dg/speeches/
                       detail/who-director-general-s-opening-remarks-at-the-media-briefing-
                       on-covid-19---24-february-2020 (Accessed on February 26, 2020).
                   5.  Chen N, Zhou M, Dong X, et al. Epidemiological and clinical charac-
                       teristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,
                       China: a descriptive study. The Lancet, 395(10223); (2020). 507-513.
                   6.   Zhang C, Wu Z, Li JW, Zhao H, et al. (2020). The cytokine release
                       syndrome (CRS) of severe COVID- 19 and Interleukin-6 receptor (IL-
                       6R) antagonist Tocilizumab may be the key to reduce the mortality.
                       Int J ofAntimicrobial Agents, doi:10.1016/j.ijantimicag. 2020.105954.
                   7.   Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are
                       associated with poor prognosis in patients with novel coronavirus
                       pneumonia. Journal of Thrombosis and Haemostasis. Doi: 10.1111/jth.
                       (2020). 14768
                   8.   Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition
                       and management of coagulopathy in COVID_19. Journal of Throm-
                       bosis and Haemostasis.https://doi.org/10.1111/jth.14810 Doi:
                       10.1111/jth. (2020). 14810.
                   9.   Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and
                       the cardiovascular system: acute and long-term implications. Eur-
                       Heart J  Mar 18. [Epub ahead of print], doi: 10.1093/eurheartj/ehaa.
                       2020.231.




                       568
   564   565   566   567   568   569   570   571   572   573   574